Risk factors
Si-Bone (SIBN) risk factors
Item 1A of every Si-Bone, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors62 risks8 new16 dropped22 reworded
Medicare reimbursement rates for CPT Code 27279 and 27278 drive adoption risks for iFuse products.
Filed Feb 24, 2026 - FY2024 10-K risk factors70 risks
SI-BONE faces ongoing operating losses with an accumulated deficit of $431.4 million as of December 31, 2024. The company relies heavily on third-party suppliers like RMS for key implants and faces intense pricing and reimbursement pressures. Operations are subject to stringent FDA regulations and the adoption risks of the iFuse family of implants.
Filed Feb 25, 2025